August 1, 2003 Issue of JAMA Neurology

August 2003, Vol 60, No. 8, Pages 1038-1179

Editorial

Nonsteroidal Anti-inflammatory Drugs Protect Against Parkinson Neurodegeneration: Can an NSAID a Day Keep Parkinson Disease Away?

Mya Schiess, MD

Abstract Full Text

Arch Neurol. 2003;60(8):1043-1044. doi:10.1001/archneur.60.8.1043

Original Contribution

Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease

Honglei Chen, MD, PhD; Shumin M. Zhang, MD, ScD; Miguel A. Hernán, MD, DrPH; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1059-1064. doi:10.1001/archneur.60.8.1059

Editorial
Nonsteroidal Anti-inflammatory Drugs Protect Against Parkinson Neurodegeneration: Can an NSAID a Day Keep Parkinson Disease Away?
Mya Schiess, MD

Arch Neurol

MRI-Guided SPECT Perfusion Measures and Volumetric MRI in Prodromal Alzheimer Disease

Georges El Fakhri, PhD; Marie Foley Kijewski, ScD; Keith A. Johnson, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1066-1072. doi:10.1001/archneur.60.8.1066

Remyelinated Lesions in Multiple Sclerosis: Magnetic Resonance Image Appearance

Frederik Barkhof, MD, PhD; Wolfgang Brück, MD, PhD; Corline J. A. De Groot, PhD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1073-1081. doi:10.1001/archneur.60.8.1073

Excitatory Amino Acids and Multiple Sclerosis: Evidence From Cerebrospinal Fluid

Paola Sarchielli, MD; Laura Greco, MD; Ardesio Floridi, PhD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1082-1088. doi:10.1001/archneur.60.8.1082

Pain in Patients With Multiple Sclerosis: A Population-Based Study

Kristina Bacher Svendsen, MD; Troels Staehelin Jensen, MD; Kim Overvad, PhD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1089-1094. doi:10.1001/archneur.60.8.1089

Prevalence of Dentatorubral-Pallidoluysian Atrophy in a Large Series of White Patients With Cerebellar Ataxia

Isabelle Le Ber, MD; Agnès Camuzat, BS; Giovanni Castelnovo, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1097-1099. doi:10.1001/archneur.60.8.1097

Evolving Antiepileptic Drug Treatment in Juvenile Myoclonic Epilepsy

Avinash Prasad, MD; Ruben I. Kuzniecky, MD; Robert C. Knowlton, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1100-1105. doi:10.1001/archneur.60.8.1100

Evidence of Subtle Gray-Matter Pathologic Changes in Healthy Elderly Individuals With Nonspecific White-Matter Hyperintensities

Domenico Maria Mezzapesa, MD; Maria Assunta Rocca, MD; Elisabetta Pagani, PhD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1109-1112. doi:10.1001/archneur.60.8.1109

Subtle Cognitive Impairment but No Dementia in Patients With Spastin Mutations

Chantal M. E. Tallaksen, MD, PhD; Elodie Guichart-Gomez; Patrice Verpillat, MD, PhD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1113-1118. doi:10.1001/archneur.60.8.1113

Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census

Liesi E. Hebert, ScD; Paul A. Scherr, ScD; Julia L. Bienias, ScD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1119-1122. doi:10.1001/archneur.60.8.1119

Blood Pressure and Cognitive Impairment in India and the United States: A Cross-National Epidemiological Study

Rajesh Pandav, MBBS, MPH; Hiroko H. Dodge, PhD; Steven T. DeKosky, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1123-1128. doi:10.1001/archneur.60.8.1123

Reliability of 4 Outcome Measures in Pediatric Spinal Muscular Atrophy

Susan T. Iannaccone, MD; Linda S. Hynan, PhD; and the American Spinal Muscular Atrophy Randomized Trials (AmSMART) Group

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1130-1136. doi:10.1001/archneur.60.8.1130

The Rate of Cognitive Decline and Risk of Reaching Clinical Milestones in Alzheimer Disease

Roee Holtzer, PhD; Domonick J. Wegesin, PhD; Steven M. Albert, PhD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1137-1142. doi:10.1001/archneur.60.8.1137

Preservation of Brain Nerve Growth Factor in Mild Cognitive Impairment and Alzheimer Disease

Elliott J. Mufson, PhD; Milos D. Ikonomovic, MD; Scot D. Styren, PhD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1143-1148. doi:10.1001/archneur.60.8.1143

Images in Neurology

What Can be Worse Than Cerebral Tuberculosis?A Concommitant Aspergillus Infection

Sevasti Bostantjopoulou, MD; Zoe Katsarou, MD; Ioannis Tsitouridis, MD; et al.

Abstract Full Text

Arch Neurol. 2003;60(8):1163-1164. doi:10.1001/archneur.60.8.1163

Observation

A Novel Mutation in the PSEN2 Gene (T430M) Associated With Variable Expression in a Family With Early-Onset Alzheimer Disease

Mario Ezquerra, PhD; Alberto Lleó, MD, PhD; Magda Castellví, PsyD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1149-1151. doi:10.1001/archneur.60.8.1149

"Computed Tomography鈥揘egative" Intracerebral Hemorrhage: Case Report and Implications for Management

Andreja S. Packard, MD, PhD; Carlos S. Kase, MD; Ahmed S. Aly, MD; et al.

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1156-1159. doi:10.1001/archneur.60.8.1156

Fulminating Adult-Onset Subacute Sclerosing Panencephalitis in a 49-Year-Old Man

Alexis Gagnon, MD; Rémi W. Bouchard, MD, MSc, FRCPC

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1160-1161. doi:10.1001/archneur.60.8.1160

Correction

Dietary Fats and the Risk of Incident Alzheimer Disease鈥擟orrection

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1072. doi:10.1001/archneur.60.8.1072

This Month in Archives of Neurology

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1040-1041. doi:10.1001/archneur.60.8.1040

Neurological Review

The Hereditary Spastic Paraplegias: Nine Genes and Counting

John K. Fink, MD

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1045-1049. doi:10.1001/archneur.60.8.1045

Basic Science Seminars in Neurology

Support of Progress in Clinical Neurology by Models of Genetic Regulation

Paul Smolen, PhD; John H. Byrne, PhD

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1053-1057. doi:10.1001/archneur.60.8.1053

Call for Papers

ARCHIVES Express

Roger N. Rosenberg, MD

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1057. doi:10.1001/archneur.60.8.1057

History of Neurology: Seminal Citations

Neurosarcoidosis

Ted M. Burns, MD

Abstract Full Text

Arch Neurol. 2003;60(8):1166-1168. doi:10.1001/archneur.60.8.1166

CME Announcement

Online CME to Begin in Fall 2003

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1168. doi:10.1001/archneur.60.6.876

Online CME to Begin in Fall 2003

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1168. doi:10.1001/archneur.60.8.1168

Correspondence

Routine Insonation of the Transorbital Window for Confirming Brain Death: a Double-Edged Sword

Gabriel R. de Freitas, MD; Charles André, MD, PhD

Abstract Full Text

Arch Neurol. 2003;60(8):1169. doi:10.1001/archneur.60.8.1169-a

Affected Side and Risk of Pain Recurrence After Surgery for Trigeminal Neuralgia

Brett Cucchiara, MD; Steven Messé, MD

Abstract Full Text

Arch Neurol. 2003;60(8):1169-1170. doi:10.1001/archneur.60.8.1169-a

Coenzyme Q10 in Early Parkinson Disease

Douglas A. Hunter, PhD

Abstract Full Text

Arch Neurol. 2003;60(8):1170. doi:10.1001/archneur.60.8.1170-a

The Effect of Coenzyme Q10 Therapy in Parkinson Disease Could Be Symptomatic

Martin W. I. M. Horstink, MD, PhD; Baziel G. van Engelen, MD, PhD

Abstract Full Text

Arch Neurol. 2003;60(8):1170-1172. doi:10.1001/archneur.60.8.1170-a

The Effect of Coenzyme Q10 Therapy in Parkinson Disease Could Be Symptomatic鈥擱eply

Clifford W. Shults, MD; Richard Haas, MB; David Oakes, PhD; et al.

Abstract Full Text

Arch Neurol. 2003;60(8):1172-1173. doi:10.1001/archneur.60.8.1172

Calendar

August 2003-April 2004

Abstract Full Text

free access

Arch Neurol. 2003;60(8):1174. doi:10.1001/archneur.60.8.1174

October 2024 - July 1959

Decade

Year

Issue

August 2003, Vol 60, No. 8, Pages 1038-1179